Cardio Diagnostics Holdings, Inc. (CDIOW)

US — Healthcare Sector
Peers: CDIO  REVBW  ICUCW  OABIW  OCEAW 

Automate Your Wheel Strategy on CDIOW

With Tiblio's Option Bot, you can configure your own wheel strategy including CDIOW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CDIOW
  • Rev/Share 0.0118
  • Book/Share 6.7474
  • PB 0.7395
  • Debt/Equity 0.0532
  • CurrentRatio 19.4879
  • ROIC -0.4873

 

  • MktCap 8676163.0
  • FreeCF/Share -3.1977
  • PFCF -1.6092
  • PE -1.4371
  • Debt/Assets 0.0493
  • DivYield 0
  • ROE -0.8456

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 5
  • P/B Score 5
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Cardio Diagnostics Holdings, Inc. (CDIOW)

  • IPO Date
  • Website https://cardiodiagnosticsinc.com
  • Industry Biotechnology
  • CEO Dr. Meeshanthini V. Dogan Ph.D.
  • Employees 13
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.